US 9,808,425 B2
Targeted liposomes in cancer therapy
Maria Polikandritou Lambros, Pomona, CA (US); Ying Huang, Pomona, CA (US); and Hari Chandana Mulamalla, Monroe Township, NJ (US)
Assigned to WESTERN UNIVERSITY OF HEALTH SCIENCES, Pomona, CA (US)
Appl. No. 14/240,753
Filed by Maria Polikandritou Lambros, Pomona, CA (US); Ying Huang, Pomona, CA (US); and Hari Chandana Mulamalla, Monroe Township, NJ (US)
PCT Filed Sep. 10, 2012, PCT No. PCT/US2012/054463
§ 371(c)(1), (2), (4) Date Jun. 9, 2014,
PCT Pub. No. WO2013/036931, PCT Pub. Date Mar. 14, 2013.
Claims priority of provisional application 61/532,430, filed on Sep. 8, 2011.
Prior Publication US 2015/0157571 A1, Jun. 11, 2015
Int. Cl. A61K 9/127 (2006.01); A61K 47/48 (2006.01); A61K 31/704 (2006.01)
CPC A61K 9/1271 (2013.01) [A61K 31/704 (2013.01); A61K 47/48815 (2013.01)] 8 Claims
OG exemplary drawing
 
1. A vehicle for the targeted intracellular delivery of a therapeutic agent or a diagnostic agent, or both, the vehicle comprising a cystine molecule coupled to a cargo, wherein the cargo is a liposome composition comprising a therapeutic agent, a diagnostic agent, or both, wherein the cystine is a targeting component.